血浆交换市场规模、份额、成长分析、按产品、按技术、按程序、按应用、按最终用户、按地区 - 行业预测，2025-2032 年

2023年血浆交换市场规模为12.4亿美元，从2024年的13.4亿美元成长到2032年的24.1亿美元，复合年增长率预计为7.7%。

由于各种宏观经济和微观经济因素，全球血浆交换产业有望显着成长。医疗保健支出的增加，特别是在中东和亚太地区，正在推动人们对先进医疗的日益关注。此外，人们对重症肌无力和狼疮等免疫系统疾病治疗方案的认识不断提高，预计将推动市场需求。根据市场预估与预测，2022年至2028年该市场预计将成长约79bp，占自体免疫疾病诊断产业的35.9%以上，预计复合年增长率为21.1%。预计将达到 12 亿美元，到 2021年终将达到 13 亿美元，复合年增长率为 4.6%，其中北美市场处于领先地位。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 宏观经济指标
• 价值链分析
• 价格分析

血浆交易市场规模：依产品分类

• 市场概况
• 装置
• 一次性的

血浆交易市场规模：依技术分类

• 市场概况
• 薄膜过滤
• 离心

血浆交易市场规模：按程序

• 市场概况
• 照光治疗
• 低密度脂蛋白单采术
• 血小板成分采集
• 白血球去除手术
• 红血球去除疗法

血浆交换市场规模：依应用分类

• 市场概况
• 血浆采集源
• 治疗性血浆置换
• 免疫学
• 神经病学
• 血液学
• 加护治疗
• 肿瘤学
• 风湿病学/整形外科
• 其他治疗用途

血浆交换市场规模：依最终用户划分

• 市场概况
• 血库和血浆采集中心
• 医院/诊所
• 生物製药公司
• 其他最终用户

血浆交易所市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2022-2024）

主要企业简介

• CSL Limited（Australia）
• Takeda Pharmaceutical Company Limited（Japan）
• Grifols, SA（Spain）
• Baxter International Inc.（United States）
• Kedrion SpA（Italy）
• Octapharma AG（Switzerland）
• Asahi Kasei Medical Co., Ltd.（Japan）
• B. Braun Melsungen AG（Germany）
• Fresenius SE & Co. KGaA（Germany）
• Terumo BCT, Inc.（United States）
• Haemonetics Corporation（United States）
• Cerus Corporation（United States）
• Nikkiso Co., Ltd.（Japan）
• Kawasumi Laboratories, Inc.（Japan）
• Macopharma SA（France）
• Shanghai RAAS Blood Products Co., Ltd.（China）
• China Biologic Products Holdings, Inc.（China）
• LFB SA（France）
• Bio Products Laboratory Ltd.（United Kingdom）
• Sanquin Blood Supply Foundation（Netherlands）

结论和建议

Plasmapheresis Market size was valued at USD 1.24 Billion in 2023 and is poised to grow from USD 1.34 Billion in 2024 to USD 2.41 Billion by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).

The global plasmapheresis industry is poised for significant growth due to a variety of macroeconomic and microeconomic factors. Increased healthcare spending, particularly in the Middle East and Asia-Pacific regions, is driving a greater focus on advanced medical therapies. Additionally, heightened awareness of treatment options for immune system disorders such as myasthenia gravis and lupus is expected to fuel market demand. Projections indicate a growth of approximately 79 basis points from 2022 to 2028, with the market catering to over 35.9% of the autoimmune disease diagnostics sector, which is estimated to grow at a 21.1% CAGR. The market experienced a 4.6% CAGR increase to reach USD 1.2 billion by the end of 2021 and is anticipated to reach USD 1.3 billion, with North America leading the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Plasmapheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Plasmapheresis Market Segmental Analysis

Global Plasmapheresis Market is segmented by product, technology, procedure, application, end user and region. Based on product, the market is segmented into instruments and disposables. Based on technology, the market is segmented into membrane filtration and centrifugation. Based on procedure, the market is segmented into photopheresis, Ldl apheresis, plateletpheresis, leukapheresis and erythrocytapheresis. Based on application, the market is segmented into source plasma collection, therapeutic plasmapheresis, immunology, neurology, hematology, critical care, oncology, rheumatology & orthopedics and other therapeutic applications. Based on end user, the market is segmented into blood banks & plasma collection centers, hospital & clinics, biopharmaceutical companies and other end user. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Plasmapheresis Market

The plasmapheresis market is poised for growth, largely driven by its critical role in managing a range of autoimmune disorders, including thrombotic thrombocytopenic purpura, Guillain-Barre syndrome, Myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. As the prevalence of these conditions rises, so does the demand for plasmapheresis equipment. Additionally, increasing awareness among end-users and a heightened focus on enhancing healthcare infrastructure are anticipated to propel market expansion. The growing healthcare investments in regions such as the Middle East, Africa, and Asia Pacific are further expected to drive the adoption of advanced treatment methods, thereby boosting the plasmapheresis industry during the forecast period.

Restraints in the Plasmapheresis Market

The plasmapheresis market faces certain restraints primarily due to concerns regarding adverse effects associated with the procedure. Although these side effects, which can include decreased arterial blood pressure, arrhythmias, transient increases in body temperature, and paresthesia, are generally mild, they can still deter potential patients from opting for this therapy. Consequently, these safety concerns may hinder the overall adoption of plasmapheresis, impacting its growth in the market. As such, market players could experience challenges during the evaluation period due to a decline in the utilization of plasmapheresis as a viable treatment option, affecting their overall market performance.

Market Trends of the Plasmapheresis Market

The plasmapheresis market is poised for significant growth, fueled by the escalating demand for effective treatments for various ailments including anemia, blood disorders, and autoimmune diseases. Innovations in apheresis technology, driven by advancements in healthcare infrastructure and increased investments in research and development, are enhancing the efficiency and safety of plasmapheresis procedures. Furthermore, the rising awareness of the therapeutic benefits of plasma exchange therapies is catalyzing a surge in blood donation rates. As healthcare organizations focus on optimizing plasmapheresis equipment worldwide, the market is expected to expand robustly in the coming years, driven by these pivotal trends and advancements.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Plasmapheresis Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Disposables

Global Plasmapheresis Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Membrane Filtration
• Centrifugation

Global Plasmapheresis Market Size by Procedure & CAGR (2025-2032)

• Market Overview
• Photopheresis
• Ldl Apheresis
• Plateletpheresis
• Leukapheresis
• Erythrocytapheresis

Global Plasmapheresis Market Size by Application & CAGR (2025-2032)

• Market Overview
• Source Plasma Collection
• Therapeutic Plasmapheresis
• Immunology
• Neurology
• Hematology
• Critical Care
• Oncology
• Rheumatology & Orthopedics
• Other Therapeutic Applications

Global Plasmapheresis Market Size by End User & CAGR (2025-2032)

• Market Overview
• Blood Banks & Plasma Collection Centers
• Hospital & Clinics
• Biopharmaceutical Companies
• Other End User

Global Plasmapheresis Market Size & CAGR (2025-2032)

• North America (Product, Technology, Procedure, Application, End User)
  • US
  • Canada
• Europe (Product, Technology, Procedure, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Procedure, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Procedure, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Procedure, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kedrion S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Octapharma AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Medical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo BCT, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerus Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kawasumi Laboratories, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai RAAS Blood Products Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• China Biologic Products Holdings, Inc. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LFB S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Products Laboratory Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanquin Blood Supply Foundation (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations